- Presentations
- 3
- Markets
- 1
Alhemo is a brand of Concizumab marketed by Novo Nordisk, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Concizumab
- Brand owner
- Novo Nordisk
- Registered in
- United States
- Strengths and forms
- 150 mg/1.5 mL injection, 300 mg/3 mL injection, 60 mg/1.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Alhemo 150 mg/1.5 mL injectionSubcutaneous Cold chain | Novo Nordisk | US FDA | Available on request |
| Alhemo 300 mg/3 mL injectionSubcutaneous Cold chain | Novo Nordisk | US FDA | Available on request |
| Alhemo 60 mg/1.5 mL injectionSubcutaneous Cold chain | Novo Nordisk | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Alhemo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.